Publications by authors named "M Ogihara"

The co-mitogenic effects of the α-adrenoceptor agonist phenylephrine on S-allyl-L-cysteine (SAC)-induced hepatocyte proliferation were examined in primary cultures of adult rat hepatocytes. The combination of phenylephrine (10-10 M) and SAC (10 M) exhibited a significant dose-dependent increase in the number of hepatocyte nuclei and viable cells compared to SAC alone. This combination also increased the progression of hepatocyte nuclei into the S-phase.

View Article and Find Full Text PDF

Background: Type 1 diabetes (T1D) is a devastating autoimmune disease, and its rising prevalence in the United States and around the world presents a critical problem in public health. While some treatment options exist for patients already diagnosed, individuals considered at risk for developing T1D and who are still in the early stages of their disease pathogenesis without symptoms have no options for any preventive intervention. This is because of the uncertainty in determining their risk level and in predicting with high confidence who will progress, or not, to clinical diagnosis.

View Article and Find Full Text PDF

Background: Biomarkers of early pathogenesis of type 1 diabetes (T1D) are crucial to enable effective prevention measures in at-risk populations before significant damage occurs to their insulin producing beta-cell mass. We recently introduced the concept of integrated parallel multi-omics and employed a novel data augmentation approach which identified promising candidate biomarkers from a small cohort of high-risk T1D subjects. We now validate selected biomarkers to generate a potential composite signature of T1D risk.

View Article and Find Full Text PDF
Article Synopsis
  • Clinical practice guidelines recommend optimal medical therapy (OMT) for patients with stable ischemic heart disease (SIHD), focusing on lifestyle changes, medications, and exercise-based cardiac rehabilitation (CR).
  • The Pre-START study is a pilot study aimed at assessing the efficacy and safety of CR specifically for Japanese patients with SIHD who have not undergone revascularization, including 36 outpatient CR sessions within 5 months.
  • The primary goal is to measure changes in health-related quality of life and exercise capacity over 6 months, providing crucial data for future studies on CR in SIHD patients.
View Article and Find Full Text PDF

We have studied whether growth factors, cytokines, hormones, neurotransmitters, and local hormones (autacoids) promote the proliferation of hepatic parenchymal cells (i.e., hepatocytes) using in vitro primary cultured hepatocytes.

View Article and Find Full Text PDF